Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Lymphatic Malformation Institute


Address

7475 Wisconsin Ave
Suite 600
Bethesda, MD 20814

Description

The Lymphatic Malformation Institute (LMI) was founded in 2010 and is focused on advancing the understanding of the lymphatic system, specifically, advancing the understanding of rare lymphatic malformations, lymphangiomatosis and Gorham’s disease. Gorham’s disease (GD) is a rare bone disorder that is characterized by bone loss (osteolysis) often associated with swelling or abnormal blood vessel growth (angiomatous proliferation). Bone loss can occur in just one bone or spread to soft tissue and adjacent bones. Lymphangiomatosis is a condition wherein cysts are formed due to the number and size of abnormally connected lymphatic channels. It can affect the cardiothoracic, abdominal, or skeletal systems. Symptoms vary depending on the system involved but ultimately, it causes restrictive compression of vital organ structures. The goal of the LMI is to find cures and treatments for these life-threatening disorders by identifying, organizing and funding research studies The LMI has established a grant program that awards seed money to researchers.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.